Viewing Study NCT01095835


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-30 @ 9:41 PM
Study NCT ID: NCT01095835
Status: COMPLETED
Last Update Posted: 2016-11-03
First Post: 2010-03-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)
Sponsor: Hoffmann-La Roche
Organization: